<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.dailyrx.com"  xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
 <title>www.dailyrx.com - Medication Leaflet</title>
 <link>http://www.dailyrx.com/taxonomy/term/149/0</link>
 <description></description>
 <language>en</language>
<item>
 <title>Tylenol Extra Strength Caplets, 225 Count Bottles Recalled</title>
 <link>http://www.dailyrx.com/fda-alerts/tylenol-extra-strength-caplets-225-count-bottles-recalled-due-uncharacteristic-odor-14371</link>
 <description>&lt;div class=&quot;field field-type-filefield field-field-photo&quot;&gt;
    &lt;div class=&quot;field-items&quot;&gt;
            &lt;div class=&quot;field-item odd&quot;&gt;
                    &lt;a href=&quot;http://www.dailyrx.com/fda-alerts/tylenol-extra-strength-caplets-225-count-bottles-recalled-due-uncharacteristic-odor-14371&quot; class=&quot;imagecache imagecache-ThumbNail imagecache-linked imagecache-ThumbNail_linked&quot;&gt;&lt;img src=&quot;http://images1.dailyrx.com/sites/www.dailyrx.com/files/imagecache/ThumbNail/photo/fda_logo.jpg&quot; alt=&quot;&quot; title=&quot;&quot; width=&quot;150&quot; height=&quot;100&quot; class=&quot;imagecache imagecache-ThumbNail&quot;/&gt;&lt;/a&gt;        &lt;/div&gt;
        &lt;/div&gt;
&lt;/div&gt;
&lt;!--paging_filter--&gt;&lt;p&gt;
	McNeil Consumer Healthcare is recalling one product lot of Tylenol Extra Strength Caplets, 225 count bottles, distributed in the U.S.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.dailyrx.com/fda-alerts/tylenol-extra-strength-caplets-225-count-bottles-recalled-due-uncharacteristic-odor-14371&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.dailyrx.com/conditions/neuromuscular-disease/migraineheadaches">Migraine/Headaches</category>
 <category domain="http://www.dailyrx.com/topics/fda">FDA</category>
 <category domain="http://www.dailyrx.com/topics/news/fda-recalls-and-alerts">FDA Recalls and Alerts</category>
 <pubDate>Mon, 04 Jul 2011 10:36:04 +0000</pubDate>
 <dc:creator>Stephanie Cheng</dc:creator>
 <guid isPermaLink="false">14371 at http://www.dailyrx.com</guid>
</item>
<item>
 <title>Asacol HD Delayed-release Tablets Earn FDA OK</title>
 <link>http://www.dailyrx.com/medication-leaflet/asacol-hd-delayed-release-tablets-earn-fda-ok-927.html</link>
 <description>&lt;p&gt;Procter &amp;amp; Gamble Pharmaceuticals has announced the availability of Asacol HD (mesalamine) delayed-release tablets, which are approved to treat moderately active ulcerative colitis (UC), a form of inflammatory bowel disease.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://www.dailyrx.com/medication-leaflet/asacol-hd-delayed-release-tablets-earn-fda-ok-927.html&quot; target=&quot;_blank&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.dailyrx.com/conditions/gastrointestinal/ulcerative-colitis">Ulcerative Colitis</category>
 <category domain="http://www.dailyrx.com/conditions/gastrointestinal">Gastrointestinal</category>
 <category domain="http://www.dailyrx.com/medications/asacol">Asacol</category>
 <category domain="http://www.dailyrx.com/topics/news/fda-drug-approvals">FDA Drug Approvals</category>
 <pubDate>Wed, 08 Jul 2009 16:59:40 +0000</pubDate>
 <dc:creator>Sarah Naseem Walker</dc:creator>
 <guid isPermaLink="false">927 at http://www.dailyrx.com</guid>
</item>
</channel>
</rss>


